INTECH Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Sell
13,744
-386
-3% -$5.51K ﹤0.01% 1848
2026
Q1
$237K Sell
14,130
-6,958
-33% -$124K ﹤0.01% 1671
2025
Q4
$338K Sell
21,088
-23,416
-53% -$349K ﹤0.01% 1701
2025
Q3
$550K Buy
44,504
+2,801
+7% +$32.8K ﹤0.01% 1526
2025
Q2
$480K Sell
41,703
-5,465
-12% -$64.8K ﹤0.01% 1629
2025
Q1
$707K Buy
47,168
+5,787
+14% +$96.9K 0.01% 1417
2024
Q4
$716K Buy
+41,381
New +$798K 0.01% 1347
2024
Q3
Sell
-11,129
Closed -$226K 2030
2024
Q2
$226K Buy
+11,129
New +$197K ﹤0.01% 1035

Other funds holding CLB

INTECH Investment Management's CLB Position: Q2 2026 in Review

INTECH Investment Management reduced its Core Laboratories (CLB) stake by 2.7% in Q2 2026, selling an estimated $5.51K and leaving 13,744 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

INTECH Investment Management first reported a position in CLB in Q2 2024 and has held it in 8 quarters since. The position peaked at $716K in Q4 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • INTECH Investment Management held 13,744 shares of Core Laboratories worth $160K as of Q2 2026.
  • INTECH Investment Management sold 386 Core Laboratories shares in Q2 2026, an estimated $5.51K.
  • Core Laboratories made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1848 holding.
  • INTECH Investment Management first reported a position in Core Laboratories in Q2 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Core Laboratories position peaked at $716K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.